Richard E. Lowenthal

Director & PRESIDENT AND CEO

Director & PRESIDENT AND CEO at ARS Pharmaceuticals, Inc., filing insider transactions on 2025-08-21.

Total Purchases

—

0 transactions

Total Sales

$724K

1 transaction

Companies Traded

1 total filings

Active Since

2025-08-21

Last: 2025-08-21

Companies

ARS Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2025-08-21	SPRY	Sale	50.0K	$14.49	$724K	1.20M	SEC ↗